PEPTOMYC
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
PEPTOMYC
Peptomyc SL is a spin-off company of the vall d´hebron institute of oncology (vhio) and the catalan institute of research and advanced studies (icrea) based in barcelonaspain. It was founded by dr. laura soucek and dr. marie-eve beaulieu. peptomyc focuses on the discovery and translation of its proprietary drugs for cancer treatment up to the clinical demonstration of safety and efficacy and out-licensing to a larger pharmaceutical entity for their commercialization.
Industries & Technologies
Financial data
Other information
Funding
2.5M € (October 2023)
capital
Investors: EIC Fund
25.5M € (January 2022)
Minority stake unknown %
Investors: HEALTHEQUITY, ALTA LIFE SCIENCES, AURORA SCIENCE, InviierteMeSL
11.4M € (December 2020)
Minority stake unknown %
Investors: CDTI, HEALTHEQUITY, ALTA LIFE SCIENCES, AURORA SCIENCE
4.2M € (September 2017)
Minority stake unknown %
Investors: ALTAMAR (ALTA LIFE SCIENCE)
1M € (April 2016)
Minority stake unknown %
Investors: INSTITUTIONAL INVESTORS, BUSINESS ANGEL CONSORTIUM, HEALTHEQUITY SCR SA
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
Other startups near startup PEPTOMYC
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.